Related Experiment Video
Updated: Feb 21, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc
Kenechukwu Mezue1, Abhinav Goyal1, Gregg S Pressman2
1Department of Internal Medicine, Einstein Medical Center, USA.
Insights
Visit-to-visit diastolic blood pressure variability independently predicts worse cardiovascular outcomes and adverse events in patients with chronic kidney disease. This finding highlights the importance of monitoring blood pressure fluctuations.
Area of Science:
- Cardiology
- Nephrology
- Clinical Trials
Background:
- Visit-to-visit blood pressure variability is linked to adverse cardiovascular outcomes.
- The SPRINT trial provides a dataset to explore this relationship in patients with chronic kidney disease (CKD).
Purpose of the Study:
- To investigate the association between blood pressure variability and cardiovascular outcomes.
- To examine the link between blood pressure variability and hypoperfusion-related adverse events in CKD patients undergoing antihypertensive therapy.
Main Methods:
- Analysis of data from the SPRINT trial, including patients with CKD.
- Characterization of diastolic blood pressure (DBP) variability using coefficients of variation (CV).
- Cox proportional hazards regression to identify predictors of cardiovascular outcomes and adverse events like hypotension, syncope, and acute kidney injury (AKI).
Main Results:
- Diastolic blood pressure variability (DBP CV) independently predicted a higher hazard for the primary cardiovascular outcome (HR 1.126, P < 0.0001).
- DBP CV also independently predicted increased hazards for AKI (HR 1.117), syncope (HR 1.111), and hypotensive events (HR 1.104).
- These associations were consistent across both standard and intensive blood pressure treatment arms.
Conclusions:
- Visit-to-visit DBP variability is an independent predictor of adverse cardiovascular outcomes in CKD patients within the SPRINT trial.
- Increased DBP variability is also associated with a higher risk of hypoperfusion-related adverse events, including AKI, syncope, and hypotension.
- Monitoring DBP variability may be crucial for risk stratification and management in hypertensive CKD patients.
Background:
Visit-to-visit blood pressure variability has been associated with adverse cardiovascular outcomes. Using the SPRINT trial data set, we explored the relationship between blood pressure variability, cardiovascular outcomes, and hypoperfusion-related adverse events of antihypertensive therapy in patients with chronic kidney disease (CKD) enrolled in the study.
Methods:
The analyses included patients with CKD randomized in SPRINT who reached the target systolic blood pressure for their respective groups (intensive <120 mm Hg; standard <140 mm Hg). Coefficients of variation (CV) for diastolic blood pressure (DBP) for each subject characterized variability. Cox proportional hazards regression was used to identify independent predictors of the SPRINT primary outcome (including acute coronary syndrome, stroke, acute heart failure, and death from cardiovascular causes) and the 3 major side effects of therapy-hypotension, syncope, and acute kidney injury (AKI). P <0.15 on univariate analysis was required to enter the model, and P <0.05 to remain in it.
Results:
Overall, 2,488 subjects (1,273 standard; 1,124 intensive) met inclusion criteria. DBP CV predicted a greater hazard for primary outcome (hazard ratio [HR] 1.126, P < 0.0001) in the overall model as well as in separate analyses by treatment arms (standard group HR 1.107, P < 0.0001; intensive group HR 1.100, P = 0.0004). DBP CV also independently predicted a greater hazard for AKI (HR 1.117), syncope (HR 1.111), and hypotensive events (HR 1.104).
Conclusion:
Visit-to-visit DBP variability independently predicts worse cardiovascular outcomes and hypoperfusion-related adverse events in patients with CKD enrolled in SPRINT.
More Related Videos
06:51Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches
Published on: September 5, 2025
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Factors affecting Blood pressure
Physiological Factors:
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pre-Procedural Guidelines for Assessing Blood Pressure
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Errors occurring during blood pressure monitoring
Several factors...